- Evaluation of Information Consistency of Clinically Significant Drug Interactions in Tyrosine Kinase Inhibitors
-
An S, Lee JY, Ah YM
- KMID: 2510442
- Korean J Clin Pharm.
- 2020 Mar;30(1):44-50.
- doi: 10.24304/kjcp.2020.30.1.44
Background: Drug-drug interactions (DDIs) in patients using oral anticancer treatment are more common than in those using injectable anticancer agents. In addition, DDIs related to anticancer treatment are known to... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Efficacy and Safety of Nivolumab and Pembrolizumab in Elderly Cancer Patients
-
Kim HS, Jeong H, Shim MK
- KMID: 2510445
- Korean J Clin Pharm.
- 2020 Mar;30(1):11-18.
- doi: 10.24304/kjcp.2020.30.1.11
Background: Nivolumab and pembrolizumab are antagonists of the programmed death-ligand 1 (PD-L1) receptor that function as immuno-oncological agents. This study aimed to evaluate the safety and efficacy of nivolumab and... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of Potential Drug-Drug Interactions in Patients Taking HMG CoA-reductase Inhibitors
-
Lee KJ, Kim KR, Seong JM, Ryu SW, Lee HY, Cho S, Cheong Y, Nam KN, Lee YJ
- KMID: 2510443
- Korean J Clin Pharm.
- 2020 Mar;30(1):31-35.
- doi: 10.24304/kjcp.2020.30.1.31
Objective: The 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) are frequently prescribed medications worldwide for the treatment of hypercholesterolemia. Statins are considered to be well tolerated; however, they have a potential... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effects of Intrapatient Variability in Tacrolimus Concentration on Clinical Outcomes Immediately After Liver Transplantation
-
Kim E, Kim B, Cho J, Lee JH, Lee E, Yu YM, Cho JY, Lee E, Choi Y
- KMID: 2510441
- Korean J Clin Pharm.
- 2020 Mar;30(1):36-43.
- doi: 10.24304/kjcp.2020.30.1.36
Background: Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in post-transplantation maintenance therapy. The drug has a narrow therapeutic range and requires periodic therapeutic drug monitoring. Although many studies have... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case Report of Cyanopsia after Taking Sildenafil
-
Lee CH, Yoon JS, Ji E
- KMID: 2510447
- Korean J Clin Pharm.
- 2020 Mar;30(1):59-64.
- doi: 10.24304/kjcp.2020.30.1.59
The emergence of phosphodiesterase (PDE) 5 inhibitors gave rise to the solution for erectile dysfunction, starting with the development of sildenafil. Although their efficacy in treating erectile dysfunction has been... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Osteoporosis in Liver Transplant Recipients
-
Choi H, Kim B, Kim Y, Lee J, Lee E, Lee E, Cho JY, Choi Y
- KMID: 2510440
- Korean J Clin Pharm.
- 2020 Mar;30(1):51-58.
- doi: 10.24304/kjcp.2020.30.1.51
Background: Prevention of osteoporosis and bone fracture is one of the important issues for liver transplant recipients because a long history of liver disease and lifelong use of immunosuppressants, including... -
- CITED
-
- Close
- SHARE
-
- Close
- A Comparative Study on the Clinical Efficacy and Safety between Combination Therapy with CDK 4/6 Inhibitor and AI Versus AI Monotherapy in HR+/HER type2- Advanced Breast Cancer: Updated Meta-analysis
-
Kim MJ, Kim K, Cho M, Sohn K, Baek Ih
- KMID: 2510446
- Korean J Clin Pharm.
- 2020 Mar;30(1):1-10.
- doi: 10.24304/kjcp.2020.30.1.1
Objective: The aim of the study was to perform a meta-analysis of randomized clinical trials to compare the clinical efficacy and safety between combination of cyclin-dependent kinase (CDK) 4/6 inhibitors... -
- CITED
-
- Close
- SHARE
-
- Close
- Patterns of Spontaneous Adverse Events Reporting on Human Papillomavirus Vaccines according to the Applicability of Brighton Collaboration Criteria in Korea from 2008 to 2017
-
Kim MS, You SH, Park HM, Lee MT, Kang YJ, Koo H, Jung SY
- KMID: 2510444
- Korean J Clin Pharm.
- 2020 Mar;30(1):19-30.
- doi: 10.24304/kjcp.2020.30.1.19
Objective: To describe patterns of spontaneous reporting on adverse events following immunization (AEFIs) using the human papilloma virus (HPV) vaccine according to the Brighton Collaboration (BC) criteria. Methods: We used... -
- CITED
-
- Close
- SHARE
-
- Close
